arrow
M

Mauro Cives

universita degli studi di bari aldo moro
H指数:31
被引数:3,670

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cabozantinib and temozolomide in patients with advanced progressive neuroendocrine tumors: a phase 2 study

卡博替尼和替莫唑胺在晚期进展性神经内分泌肿瘤患者中的应用:一项II期研究

2026-04-100
OAAI
ARTEMIS: a pilot study comparing AI-based and expert therapeutic decisions in simulated clinical cases of neuroendocrine neoplasms

ARTEMIS:一项比较基于AI和专家治疗决策在神经内分泌肿瘤模拟临床病例中的试点研究

2025-12-230
OAAI
Bone metastases from neuroendocrine neoplasms: Results of an Italian nationwide survey of natural history and management

神经内分泌肿瘤骨转移:一项关于自然史和管理的意大利全国性调查结果

2025-11-180
OAAI
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)

非功能性晚期GEP-NENs的管理临床实践指南:意大利医学肿瘤学会(AIOM)与意大利神经内分泌肿瘤学会(ITANET)合作,采用GRADE方法进行证据评估和推荐。

2025-11-120
OAAI
Pancreatic neuroendocrine neoplasms (pNENs): Genetic and environmental biomarkers for risk of occurrence and prognosis

胰腺神经内分泌肿瘤 (pNENs): 发生风险和预后的遗传和环境生物标志物

2025-07-011
PRE
Radioligand therapy in the therapeutic strategy for patients with gastro-entero-pancreatic neuroendocrine tumors: a consensus statement from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Association of Nuclear Medicine (AIMN), Italian Society of Endocrinology (SIE), Italian Association of Medical Oncology (AIOM).
2024-10-122
OAAI
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas
2024-09-012
OAAI
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms
2024-07-011
OA
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort
2024-04-034
OAAI